Marshall Wace’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-231,913
Closed -$327K 4024
2022
Q1
$327K Buy
231,913
+103,912
+81% +$222K ﹤0.01% 2941
2021
Q4
$348K Buy
128,001
+82,419
+181% +$304K ﹤0.01% 2971
2021
Q3
$217K Buy
+45,582
New +$333K ﹤0.01% 2780
2021
Q2
Sell
-10,935
Closed -$88K 3323
2021
Q1
$88K Sell
10,935
-13,044
-54% -$122K ﹤0.01% 2364
2020
Q4
$215K Buy
23,979
+3,467
+17% +$28.8K ﹤0.01% 1735
2020
Q3
$155K Sell
20,512
-39,917
-66% -$277K ﹤0.01% 1485
2020
Q2
$385K Sell
60,429
-39,143
-39% -$262K ﹤0.01% 1267
2020
Q1
$740K Sell
99,572
-75,212
-43% -$583K 0.01% 886
2019
Q4
$1.58M Sell
174,784
-223,016
-56% -$1.87M 0.01% 872
2019
Q3
$2.98M Sell
397,800
-260,648
-40% -$1.46M 0.02% 649
2019
Q2
$3.42M Sell
658,448
-315,026
-32% -$2.05M 0.03% 607
2019
Q1
$8.15M Buy
973,474
+569,509
+141% +$4.1M 0.08% 316
2018
Q4
$1.74M Buy
403,965
+317,625
+368% +$2.81M 0.02% 766
2018
Q3
$1.26M Buy
+86,340
New +$1.43M 0.01% 766
2016
Q2
Sell
-13,510
Closed -$178K 1222
2016
Q1
$178K Buy
+13,510
New +$192K ﹤0.01% 977

Other funds holding IVC

Marshall Wace's IVC Position: Q2 2022 in Review

Marshall Wace sold out of Invacare Corporation (IVC) in Q2 2022, closing a stake of 231,913 shares — an estimated $327K sold.

Marshall Wace first reported a position in IVC in Q1 2016 and held it in 15 quarters. The position peaked at $8.15M in Q1 2019. 83 funds tracked by Wall St. Rank hold IVC as of Q2 2022.

  • Marshall Wace reported no remaining Invacare Corporation position as of Q2 2022 after selling out during the quarter.
  • Marshall Wace sold 231,913 Invacare Corporation shares in Q2 2022, an estimated $327K.
  • Marshall Wace first reported a position in Invacare Corporation in Q1 2016 and held it in 15 quarters.
  • Marshall Wace's Invacare Corporation position peaked at $8.15M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held Invacare Corporation as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.